Cargando…
From liver fibrosis to hepatocarcinogenesis: Role of excessive liver H(2)O(2) and targeting nanotherapeutics
Liver fibrosis and hepatocellular carcinoma (HCC) have been worldwide threats nowadays. Liver fibrosis is reversible in early stages but will develop precancerosis of HCC in cirrhotic stage. In pathological liver, excessive H(2)O(2) is generated and accumulated, which impacts the functionality of he...
Autores principales: | Shao, Meiyu, Wang, Yifan, Dong, Hongyan, Wang, Lu, Zhang, Xiaoqing, Han, Xin, Sang, Xianan, Bao, Yini, Peng, Mengyun, Cao, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663332/ https://www.ncbi.nlm.nih.gov/pubmed/36406254 http://dx.doi.org/10.1016/j.bioactmat.2022.11.001 |
Ejemplares similares
-
Nanodrug rescues liver fibrosis via synergistic therapy with H(2)O(2) depletion and Saikosaponin b1 sustained release
por: Peng, Mengyun, et al.
Publicado: (2023) -
Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis
por: Fabregat, Isabel, et al.
Publicado: (2018) -
Hepatocarcinogenesis in liver cirrhosis: imaging diagnosis.
por: Choi, B. I.
Publicado: (1998) -
Design of Safe Nanotherapeutics for the Excretion
of Excess Systemic Toxic Iron
por: Abbina, Srinivas, et al.
Publicado: (2019) -
Targeted Nanotherapeutics for Respiratory Diseases: Cancer, Fibrosis, and Coronavirus
por: Majumder, Joydeb, et al.
Publicado: (2020)